Science Magazine ranks Roche No. 3 among Top Employers in the Biotech and Pharmaceutical Industries
Basel, 20 October 2006
For the fifth consecutive year, Roche was named to Science’s list of Top 20 Employers in the Biotech and Pharmaceutical Industry, moving up in rank for the fourth straight year to number three on the list, selected from more than 330 companies. Genentech, also a member of the Roche Group was again ranked number one.
Roche was singled out in three areas: being an innovative leader in the industry, having work culture values that are aligned with personal values and having a clear vision of where it is headed.
“At Roche, our success is based on scientific innovation. Talented people working are the major factor in that success,” said Jonathan Knowles, member of the Roche Corporate Executive Committee and Head of Global Research. “The exciting scientific environment we have created, the unique way in which we share knowledge within the company and with our partners in our innovation network, as well as how we develop people helps us to attract new talent and retain the talented people we have,” added Knowles.
“We are very proud of the recent Science recognition and other workplace honors that validate our commitment to being an employer of choice,” said Gottlieb Keller, member of the Roche Corporate Executive Committee and head Corporate Services and Human Resources.
The Top 20 list was the result of a month-long online survey by Science of readers, subscribers and others working in the biotech and pharmaceutical industry. Participants rated 330 companies on 42 different attributes from seven different categories: corporate image, leadership and direction, financial prowess, work culture/environment, work/life balance, academics and collegial exchange, and compensation and benefits
Headquartered in Basel, Switzerland, Roche is one of the world’s leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As a supplier of innovative products and services for the early detection, prevention, diagnosis and treatment of disease, the Group contributes on a broad range of fronts to improving people’s health and quality of life. Roche is a world leader in diagnostics, the leading supplier of medicines for cancer and transplantation and a market leader in virology. In 2005 sales by the Pharmaceuticals Division totalled 27.3 billion Swiss francs, and the Diagnostics Division posted sales of 8.2 billion Swiss francs. Roche employs roughly 70,000 people in 150 countries and has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai. Additional information about the Roche Group is available on the Internet (www.roche.com).
All trademarks used or mentioned in this release are protected by law.
- Contact Information
- Martina Rupp
- Media Spokeswoman
- Contact via E-mail
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.